Find a GSK Clinical Study

Search by keywords and/or location

icon

Learn About Clinical Studies

Education about the clinical research process.

Learn More
icon

Sharing Clinical Trial Data

GSK is committed to provide access to anonymised patient-level data that sit behind the results of clinical trials. GSK-sponsored interventional clinical trials conducted with products will be listed for data sharing once a medicine has been approved by regulators or terminated from development, and the study has been accepted for publication. External researchers can request access to anonymised patient-level clinical trial data and supporting clinical trial documents through the multi-sponsor data sharing portals. It is hoped that sharing these data with researchers will help to further scientific research, increase understanding of new and current medicines and ultimately improve patient care.

Learn More
icon

About the GSK Study Register

The GSK Study Register provides information on our studies and publications.

Learn More
icon

Layperson Summary of Clinical Trial Results

GSK is committed to developing Layperson Summaries of Clinical Trial Results (also referred to as Plain Language Summaries) in a way that is understandable by members of the general public. Sharing these summaries is a crucial part of showing respect to volunteers who participated in our clinical trials and our commitment to providing access to information about our research and their results to patients, healthcare providers and the wider public.

Learn More

About the GSK Study Register

The GSK Study Register provides information about studies such as study documents, locations and eligibility criteria for participating. The information is useful for researchers and patients. It supplements information presented in scientific journals, at scientific congresses, in letters to healthcare professionals, and in approved prescribing information. We aim to publish our clinical research as papers in the scientific literature.

We provide publication citations with studies on this register. Where there is no citation the study has not yet been published. For a small number of studies, a publication is not being progressed. This may be because it has been rejected by journals or because it is unlikely to be published by journals - for example where a study is terminated early with little or no data.

GSK has alliances with other organisations. As part of these alliances, GSK may not have been the regulatory sponsor of all clinical studies for a product and therefore the results of such studies may not appear on this register. Please see other public registries such as ClinicalTrials.gov or EU Clinical Trials Register for any study disclosures from our alliance partners.

Doctor or Physician in their office

Clinical Study Transparency

GSK’s Long-Standing Commitment
to Clinical Study Transparency

We recognise the importance of publicly disclosing clinical research on our products. In 2004 we introduced the GSK Study Register, a place where anyone can access information about the clinical research we carry out. We were the first pharmaceutical company to do this.

Our clinical study results are made public regardless of whether they are positive or negative. When a study begins, we post a protocol summary, which includes the study’s objectives and design. Once the study has completed, we provide a summary of the results. We also disclose full protocols, statistical analysis plans, clinical study reports and regulatory overview documents as well as list studies for data sharing. Click here to find more information about our commitments.

Researcher examining clinical study results
upBack to Top